Galenus von Pergamon Prize 2023-the candidates. Brukinsa® for chronic lymphocytic leukemia - highly effective and good cardiac tolerance

被引：0

|

作者：

不详

机构：

来源：

INNERE MEDIZIN | 2023年 / 64卷 / 09期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：906 / 906

页数：1

相关论文

共 16 条

[1] Galenus von Pergamon Prize 2023-the candidates. Kerendia® - protection of kidneys and heart in chronic kidney disease
不详
INNERE MEDIZIN, 2023, 64 (10): : 969 - 969
[2] Galenus von Pergamon Prize 2023-the candidates. Enjaymo® - Inhibition of chronic hemolysis in cold agglutinin disease
不详
INNERE MEDIZIN, 2023, 64 (09): : 863 - 863
[3] Galenus von Pergamon Prize 2023-the candidates. Follicular lymphoma: Lunsumio® is the first bispecific antibody available
不详
INNERE MEDIZIN, 2023, 64 (09): : 829 - 829
[4] Galenus von Pergamon Prize 2023-the Candidates. Kimmtrak® - first specific therapy option for uveal melanoma
不详
INNERE MEDIZIN, 2023, 64 (10): : 945 - 945
[5] Galenus von Pergamon Prize 2023-the candidates. Gastrointestinal stromal tumors: Qinlock® - opportunity in the fourth line of therapy
不详
INNERE MEDIZIN, 2023, 64 (09): : 910 - 910
[6] Galenus von Pergamon Prize 2023-the candidates. Control severe bronchial asthma: New biologic works regardless of phenotype
不详
INNERE MEDIZIN, 2023, 64 (10): : 944 - 944
[7] Galenus von Pergamon Prize 2023-the Candidates Pluvicto® - The first Radioligand Therapy for Prostate Cancer
不详
RADIOLOGIE, 2023, 63 (07): : 542 - 542
[8] Galenus von Pergamon Prize 2023-the Candidates Pluvicto® - The first Radioligand Therapy for Prostate Cancer
不详
UROLOGIE, 2023, 62 (07): : 684 - 684
[9] Galenus von Pergamon Prize 2023-the Candidates Conjugate Vaccine enhances Immune Response against Pneumococci
不详
HNO, 2023, 71 (08) : 524 - 524
[10] Galenus von Pergamon Award 2023-The Candidates. Quviviq™ - new Active Principle against overactive Waking System in Insomnia
不详
INNERE MEDIZIN, 2023, 64 (08): : 817 - 817